Literature DB >> 27262779

YAP/TAZ as therapeutic targets in cancer.

Francesca Zanconato1, Giusy Battilana1, Michelangelo Cordenonsi1, Stefano Piccolo2.   

Abstract

The biology and regulation of YAP and TAZ, two closely related transcriptional regulators, are receiving increasing attention owing to their fundamental roles in organ growth, tissue repair and cancer. In particular, the widespread activation of YAP/TAZ in carcinomas, and the crucial role of YAP/TAZ activation for many 'hallmarks' of cancer are indicating YAP/TAZ as prime targets for designing anti-cancer drugs. Here, we start from the known modalities to regulate YAP/TAZ to highlight possible routes of therapeutic intervention.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27262779      PMCID: PMC6175256          DOI: 10.1016/j.coph.2016.05.002

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  65 in total

1.  Role of TAZ as mediator of Wnt signaling.

Authors:  Luca Azzolin; Francesca Zanconato; Silvia Bresolin; Mattia Forcato; Giuseppe Basso; Silvio Bicciato; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Cell       Date:  2012-12-13       Impact factor: 41.582

2.  YAP Drives Growth by Controlling Transcriptional Pause Release from Dynamic Enhancers.

Authors:  Giorgio G Galli; Matteo Carrara; Wei-Chien Yuan; Christian Valdes-Quezada; Basanta Gurung; Brian Pepe-Mooney; Tinghu Zhang; Geert Geeven; Nathanael S Gray; Wouter de Laat; Raffaele A Calogero; Fernando D Camargo
Journal:  Mol Cell       Date:  2015-10-01       Impact factor: 17.970

3.  Transduction of mechanical and cytoskeletal cues by YAP and TAZ.

Authors:  Georg Halder; Sirio Dupont; Stefano Piccolo
Journal:  Nat Rev Mol Cell Biol       Date:  2012-08-16       Impact factor: 94.444

4.  Energy stress regulates hippo-YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein.

Authors:  Michael DeRan; Jiayi Yang; Che-Hung Shen; Eric C Peters; Julien Fitamant; Puiyee Chan; Mindy Hsieh; Shunying Zhu; John M Asara; Bin Zheng; Nabeel Bardeesy; Jun Liu; Xu Wu
Journal:  Cell Rep       Date:  2014-10-16       Impact factor: 9.423

5.  Targeting the Central Pocket in Human Transcription Factor TEAD as a Potential Cancer Therapeutic Strategy.

Authors:  Ajaybabu V Pobbati; Xiao Han; Alvin W Hung; Seetoh Weiguang; Nur Huda; Guo-Ying Chen; CongBao Kang; Cheng San Brian Chia; Xuelian Luo; Wanjin Hong; Anders Poulsen
Journal:  Structure       Date:  2015-10-22       Impact factor: 5.006

6.  Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry.

Authors:  Xiaodong Feng; Maria Sol Degese; Ramiro Iglesias-Bartolome; Jose P Vaque; Alfredo A Molinolo; Murilo Rodrigues; M Raza Zaidi; Bruce R Ksander; Glenn Merlino; Akrit Sodhi; Qianming Chen; J Silvio Gutkind
Journal:  Cancer Cell       Date:  2014-05-29       Impact factor: 31.743

7.  TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells.

Authors:  M Bartucci; R Dattilo; C Moriconi; A Pagliuca; M Mottolese; G Federici; A Di Benedetto; M Todaro; G Stassi; F Sperati; M I Amabile; E Pilozzi; M Patrizii; M Biffoni; M Maugeri-Saccà; S Piccolo; R De Maria
Journal:  Oncogene       Date:  2014-02-17       Impact factor: 9.867

8.  Tead and AP1 Coordinate Transcription and Motility.

Authors:  Xiangfan Liu; Huapeng Li; Mihir Rajurkar; Qi Li; Jennifer L Cotton; Jianhong Ou; Lihua J Zhu; Hira L Goel; Arthur M Mercurio; Joo-Seop Park; Roger J Davis; Junhao Mao
Journal:  Cell Rep       Date:  2016-01-28       Impact factor: 9.423

9.  MDP, a database linking drug response data to genomic information, identifies dasatinib and statins as a combinatorial strategy to inhibit YAP/TAZ in cancer cells.

Authors:  Cristian Taccioli; Giovanni Sorrentino; Alessandro Zannini; Jimmy Caroli; Domenico Beneventano; Laura Anderlucci; Marco Lolli; Silvio Bicciato; Giannino Del Sal
Journal:  Oncotarget       Date:  2015-11-17

10.  YAP and TAZ regulate skin wound healing.

Authors:  Min-Jung Lee; Mi Ran Byun; Makoto Furutani-Seiki; Jeong-Ho Hong; Han-Sung Jung
Journal:  J Invest Dermatol       Date:  2013-08-09       Impact factor: 8.551

View more
  77 in total

1.  Pathways Governing Polyethylenimine Polyplex Transfection in Microporous Annealed Particle Scaffolds.

Authors:  Norman F Truong; Sasha Cai Lesher-Pérez; Evan Kurt; Tatiana Segura
Journal:  Bioconjug Chem       Date:  2018-12-18       Impact factor: 4.774

Review 2.  Drug development against the hippo pathway in mesothelioma.

Authors:  Gavitt A Woodard; Yi-Lin Yang; Liang You; David M Jablons
Journal:  Transl Lung Cancer Res       Date:  2017-06

Review 3.  The assembly and function of perinuclear actin cap in migrating cells.

Authors:  Miloslava Maninova; Josef Caslavsky; Tomas Vomastek
Journal:  Protoplasma       Date:  2017-01-18       Impact factor: 3.356

4.  YAP/TAZ initiate and maintain Schwann cell myelination.

Authors:  Matthew Grove; Hyukmin Kim; Maryline Santerre; Alexander J Krupka; Seung Baek Han; Jinbin Zhai; Jennifer Y Cho; Raehee Park; Michele Harris; Seonhee Kim; Bassel E Sawaya; Shin H Kang; Mary F Barbe; Seo-Hee Cho; Michel A Lemay; Young-Jin Son
Journal:  Elife       Date:  2017-01-26       Impact factor: 8.140

5.  Platelets reduce anoikis and promote metastasis by activating YAP1 signaling.

Authors:  Monika Haemmerle; Morgan L Taylor; Tony Gutschner; Sunila Pradeep; Min Soon Cho; Jianting Sheng; Yasmin M Lyons; Archana S Nagaraja; Robert L Dood; Yunfei Wen; Lingegowda S Mangala; Jean M Hansen; Rajesha Rupaimoole; Kshipra M Gharpure; Cristian Rodriguez-Aguayo; Sun Young Yim; Ju-Seog Lee; Cristina Ivan; Wei Hu; Gabriel Lopez-Berestein; Stephen T Wong; Beth Y Karlan; Douglas A Levine; Jinsong Liu; Vahid Afshar-Kharghan; Anil K Sood
Journal:  Nat Commun       Date:  2017-08-21       Impact factor: 14.919

6.  A Novel Notch-YAP Circuit Drives Stemness and Tumorigenesis in Embryonal Rhabdomyosarcoma.

Authors:  Katherine K Slemmons; Lisa E S Crose; Stefan Riedel; Manuela Sushnitha; Brian Belyea; Corinne M Linardic
Journal:  Mol Cancer Res       Date:  2017-09-18       Impact factor: 5.852

7.  Tissue inhibitor of metalloproteinase-1 promotes cell proliferation through YAP/TAZ activation in cancer.

Authors:  T Ando; D Charindra; M Shrestha; H Umehara; I Ogawa; M Miyauchi; T Takata
Journal:  Oncogene       Date:  2017-09-18       Impact factor: 9.867

Review 8.  Targeting FAK in anticancer combination therapies.

Authors:  John C Dawson; Alan Serrels; Dwayne G Stupack; David D Schlaepfer; Margaret C Frame
Journal:  Nat Rev Cancer       Date:  2021-03-17       Impact factor: 60.716

9.  The YAP1 Signaling Inhibitors, Verteporfin and CA3, Suppress the Mesothelioma Cancer Stem Cell Phenotype.

Authors:  Sivaveera Kandasamy; Gautam Adhikary; Ellen A Rorke; Joseph S Friedberg; McKayla B Mickle; H Richard Alexander; Richard L Eckert
Journal:  Mol Cancer Res       Date:  2019-11-15       Impact factor: 5.852

Review 10.  Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview.

Authors:  Simone Brivio; Massimiliano Cadamuro; Luca Fabris; Mario Strazzabosco
Journal:  Gene Expr       Date:  2017-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.